Growth prediction models, concept and use

被引:20
作者
Kriström, B [1 ]
Wikland, KA [1 ]
机构
[1] Gothenburg Univ, Sahlgrenska Acad, Gothenburg Pediat Growth Res Ctr, Queen Silvia Childrens Hosp,Inst Hlth Womens & Ch, SE-41685 Gothenburg, Sweden
关键词
short stature; GH deficiency; children; GH treatment; growth response; tissue GH responsiveness;
D O I
10.1159/000058104
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a principal and qualitative difference between using regression results on data from groups of children, and using validated prediction models for individual children. Using accurate models, it is now possible to predict the growth response to growth hormone (GH) treatment in a slowly growing child with GH deficiency (GHD) or in a child with idiopathic short stature (ISS). The growth response to the standard dose of GH can be regarded as a bioassay for GH (i.e. the tissue GH responsiveness) and the information on this growth response can be used for different purposes: to decide about treatment or not, for monitoring, and for adjusting the GH dose in order to reach a defined goal for height. This last concept is now used in an ongoing prospective randomized GH dose-finding trial. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:66 / 70
页数:5
相关论文
共 11 条
[1]  
Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.3.CO
[2]  
2-X
[3]   PREDICTION OF THE GROWTH-RESPONSE OF SHORT PREPUBERTAL CHILDREN TREATED WITH GROWTH-HORMONE [J].
KRISTROM, B ;
KARLBERG, J ;
ALBERTSSONWIKLAND, K .
ACTA PAEDIATRICA, 1995, 84 (01) :51-57
[4]   Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-Binding protein-3 in short children with various GH secretion capacities [J].
Kristrom, B ;
Jansson, C ;
Rosberg, S ;
AlbertssonWikland, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) :2889-2898
[5]   Effect of spontaneous GH secretion and the GH sampling period on the accuracy of models for predicting growth responses to GH treatment [J].
Kriström, B ;
Löfqvist, C ;
Rosberg, S ;
Wikland, KA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4963-4964
[6]  
KRISTROM B, 1999, THESIS UMEA GOTEBORG
[7]   Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency - Analysis of 195 patients of the Kabi Pharmacia International Growth Study [J].
Ranke, MB ;
Price, DA ;
AlbertssonWikland, K ;
Maes, M ;
Lindberg, A .
HORMONE RESEARCH, 1997, 48 (02) :62-71
[8]   Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency [J].
Ranke, MB ;
Lindberg, A ;
Chatelain, P ;
Wilton, P ;
Cutfield, W ;
Albertsson-Wikland, K ;
Price, DA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) :1174-1183
[9]   Catch-up growth after childhood-onset substitution in primary hypothyroidism:: Is it a guide towards optimal growth hormone treatment in idiopathic growth hormone deficiency? [J].
Ranke, MB ;
Schwarze, CP ;
Mohnike, K ;
von Mühlendahl, KE ;
Keller, E ;
Willgerodt, H ;
Kiess, W .
HORMONE RESEARCH, 1998, 50 (05) :264-270
[10]   Effect of growth hormone (GH) during puberty in GH-deficient children:: preliminary results from an ongoing randomized trial with different dose regimens [J].
Wikland, KA ;
Alm, F ;
Aronsson, S ;
Gustafsson, J ;
Hagenäs, L ;
Häger, A ;
Ivarsson, S ;
Kriström, B ;
Marcus, C ;
Moëll, C ;
Nilsson, KO ;
Ritzén, M ;
Tuvemo, T ;
Westgren, U ;
Westphal, O ;
Åman, J .
ACTA PAEDIATRICA, 1999, 88 :80-84